Results 121 to 130 of about 969,785 (263)

Pathways to care for substance use treatment among tribal patients at a psychiatric hospital: A comparative study. [PDF]

J Neurosci Rural Pract, 2023
Balan A, Kannekanti P, Khanra S.
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Specialty Grand Challenge for NeuroRehabilitation Research

Frontiers in Neurology, 2020
Thomas Platz, Thomas Platz, Thomas Platz, Giorgio Sandrini, Giorgio Sandrini   +4 more
doaj   +1 more source

Factors that affect pathways to care for youth with psychotic disorders in Newfoundland and Labrador, Canada: A qualitative study. [PDF]

PLOS Ment Health
Giovannini-Green ZEM, Mugford G, Philpott D.   +2 more
europepmc   +1 more source

Granular analysis of pathways to care and durations of untreated psychosis: A marginal delay model. [PDF]

PLoS One, 2022
Mathis WS, Ferrara M, Burke S, Hyun E, Li F, Zhou B, Cahill J, Kline ER, Keshavan MS, Srihari VH.   +9 more
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders. [PDF]

J Neurosci Rural Pract, 2022
Nebhinani N, Pareek V, Choudhary S, Tripathi S, Singh P, Kumar M.   +5 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Structures of survival: Syndemic pathways to care among people with HIV involved with the criminal legal system. [PDF]

Soc Sci Med
Casanova FO, Puchi G, Ramirez E, Bahraini A, Bailey ZD, Nowotny KM.   +5 more
europepmc   +1 more source

Cohort profile: pathways to care among people with disorders of sex development (DSD). [PDF]

BMJ Open, 2022
Goodman M, Yacoub R, Getahun D, McCracken CE, Vupputuri S, Lash TL, Roblin D, Contreras R, Cromwell L, Gardner MD, Hoffman T, Hu H, Im TM, Prakash Asrani R, Robinson B, Xie F, Nash R, Zhang Q, Bhai SA, Venkatakrishnan K, Stoller B, Liu Y, Gullickson C, Ahmed M, Rink D, Voss A, Jung HL, Kim J, Lee PA, Sandberg DE.   +29 more
europepmc   +1 more source